Clinical Trials Using MTF-1 Inhibitor APTO-253 HCl

Clinical trials are research studies that involve people. The clinical trials on this list are studying MTF-1 Inhibitor APTO-253 HCl. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • A Study of APTO-253 in Patients With Relapsed or Refractory AML or MDS

    This study is being done to evaluate the safety and effectiveness of APTO-253 for the treatment of patients with the condition of acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS) for which either the standard treatment has failed, is no longer effective, or can no longer be administered safely or poses a risk for your general well being.
    Location: 8 locations